Pharmaceutical Intermediates and Fine Chemicals

R-phenylacetylcarbinol (PAC), an intermediate in the production of ephedrine and pseudoephedrine, is currently produced by the controlled addition of benzaldehyde to an actively growing culture of yeast (usually Saccharomyces cerevisiae). A decarboxylation/condensation biotransformation is effected by pyruvate decarboxylase (PDC) between pyruvate produced by the yeast and added benzaldehyde (see Fig. 9). Using this traditional process, 12-15 gL-1 PAC is usually produced in 10-12 h with a yield of 70% theoretical based on benzaldehyde [100].

Confirmation of PAC production from benzaldehyde and pyruvate using purified PDC from various sources, including Z. mobilis, S. carlsbergenis, S. cerevisiae, S. fermentati and S. delbrueckii, was demonstrated by sev­eral groups during the late 1980s to mid 1990s [101-105]. Bringer-Meyer et al. [106] isolated and characterized PDC obtained from Z. mobilis. By comparison with yeast PDC (Saccharomyces sp., Candida sp.), bacterial PDC (Zymomonas sp.) had a lower benzaldehyde affinity and was inhibited more strongly by benzaldehyde, even though its affinity for pyruvate was similar or higher than that of yeast PDC.

Fig. 9 Mechanism for production of pharmaceutical intermediate R-PAC from benzalde­hyde and pyruvate via decarboxylation and condensation using an enzymatic process based on pyruvate decarboxylase present in fungi, yeasts and bacteria (including Z. mo — bills)

However, interest in PDC from Z. mobilis continued due to its greater sta­bility than yeast PDC at room temperature with an enzyme half-life in the absence of benzaldehyde of over 100 h [107,108]. Unlike yeast PDC, it is also able to utilize the lower cost acetaldehyde as an alternative substrate to pyru­vate for production of PAC [109]. Advances in site-directed mutagenesis tech­niques have facilitated the production of mutant PDC from Z. mobilis with greater carboligase activity and higher stability towards acetaldehyde [110]. This mutant enzyme, designated PDCW392M, resulted from replacement of the bulky tryptophan residue 392 with methionine. A continuous process with PDCW392M was used in a biotransformation process for conversion of acetaldehyde and benzaldehyde to PAC in an enzyme membrane reactor. A volumetric productivity (space-time yield) of 81 gl-1 day-1 was reported with final PAC concentration of 22 mM and molar yields of 45% (initial sub­strates), based on 50 mM reaction mixture of both aldehydes [111,112].

In further studies by Rosche et al. [113], a biphasic enzymatic biotransfor­mation system for production of PAC from acetaldehyde and benzaldehyde with Z. mobilis PDCW392 was evaluated. Higher concentrations of benzalde — hyde and PAC in the organic phase (octanol) provided protection for the aqueous phase PDC. As a result, a specific PAC production of 11 mg PAC U PDC-1 was achieved compared with 1.2 mg PAC U PDC-1 in the absence of an organic phase. A similar two-phase system has been developed sub­sequently for conversion of pyruvate and benzaldehyde to PAC using PDC from yeast (C. utilis) with higher concentrations and productivities being at­tained [114,115].

A similar aqueous/organic two-phase system has been used also to screen a number of yeasts and bacteria for the enantio-specific reduction of the al­pha, beta-unsaturated carbon bond in citral to produce citronellal [116]. In comparison to the bacteria tested, the eukaryotes showed at least 5-fold lower citral reductase activities. Bacterial strains were found to produce the (S)- enantiomer of citronellal preferentially with ee values > 99% for Z. mobilis and 75% for Citronella freundii. The possible use of a Z. mobilis biofilm biore­actor for production of other fine chemicals has been proposed also [117] as it has been demonstrated that increased tolerance to aromatic substrates such as benzaldehyde can occur with such a bioreactor.

5